By contrast, chronic hyperglucagonemia, impaired hyperglycemia-induced suppression of glucagon and generally suppressed GH levels seem to be hallmarks of manifest T2D, thus culminating later in its development. The gene discussed is GH1; the disease is type 2 diabetes mellitus.